Suki Secures $90 Million Series E to Scale Healthcare AI Agents for Health Systems

On October 13, 2026, Suki, the leader in Ambient Clinical Intelligence (ACI), announced $90 million in Series E financing to accelerate growth and expand its healthcare AI capabilities.

The financing includes new investors Healthier Capital, Crosslink Capital, and Hercules Capital, with participation from all existing institutional investors.

Key Details

Suki's AI agents help reduce physician burnout by automating clinical documentation through voice-enabled ambient listening in examination rooms.

The company plans to use the funding to expand its AI capabilities beyond documentation to include clinical decision support, patient engagement, and care coordination features.

Existing institutional investors including Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, and Zoom Ventures participated in the round.

Why It Matters

Physician burnout remains a critical healthcare challenge, with documentation burden contributing significantly to dissatisfaction and early career attrition.

Ambient AI solutions like Suki's address this by capturing and structuring clinical information naturally during patient encounters rather than requiring post-visit data entry.

Context

The healthcare AI market continues to attract significant investment as providers seek technology solutions to improve efficiency, reduce costs, and enhance clinician experience amid ongoing workforce shortages.